Clinical Trials Browser

PRETEXT I Hepatoblastoma × Irinotecan × 90 days × Clear all

NCT00980460 2026-05-04

Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer

Phase 3 Active not recruiting

236 enrolled 18 charts

Gastrointestinal

PRETEXT I Hepatoblastoma